[Retracted] Clinical Efficacy of Methotrexate Combined with Iguratimod on Patients with Rheumatoid Arthritis and Its Influence on the Expression Levels of HOTAIR in Serum

Table 5

Comparison of adverse events of patients in the two groups after treatment ((%)).

Group	Control group ()	Research group ()
Transaminase elevation	23 (15.86)	16 (13.01)	0.436	0.509
Leukopenia	12 (8.28)	14 (11.38)	0.733	0.392
Renal and liver function damage	9 (6.21)	11 (8.94)	0.722	0.396
Dizziness	27 (18.62)	24 (19.51)	0.034	0.853
Diarrhea	19 (13.10)	23 (18.70)	1.577	0.209
Nausea and vomiting	23 (15.86)	29 (23.58)	2.533	0.112
Hypertension	7 (4.83)	5 (4.07)	0.090	0.764
Infection	15 (10.34)	10 (8.13)	0.386	0.534